StocktoriaUTime Ltd WTO
Nasdaq · XNAS · stock · Electronic & Other Electrical Equipment (No Computer Equip)
Chart by TradingView
2/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $34.6M | $24.3M | $29.2M | $43.4M | $37.6M |
| Gross profit | $976,000 | $1.2M | $4.4M | $2.2M | $2.8M |
| Operating income | -$91.6M | -$4.2M | -$12.2M | -$5.4M | -$2.2M |
| Net income | -$92.3M | -$8.6M | -$12.8M | -$6.1M | -$16.6M |
| Operating cash flow | -$4.4M | -$53.1M | -$20.3M | -$19.8M | -$3.0M |
| Free cash flow | — | -$53.2M | -$20.6M | -$20.7M | — |
| Total assets | $28.4M | $91.6M | $45.6M | $39.5M | $26.4M |
| Total liabilities | $47.4M | $40.5M | $39.6M | $29.3M | $22.6M |
| Shareholders' equity | -$19.0M | $51.8M | $5.9M | $10.2M | $3.8M |
| Ratios | |||||
| Gross margin | 2.8% | 5.2% | 15.0% | 5.0% | 7.4% |
| Operating margin | -264.8% | -17.5% | -41.9% | -12.5% | -5.9% |
| Net margin | -267.0% | -35.4% | -43.7% | -14.1% | -44.3% |
| FCF margin | — | -219.2% | -70.7% | -47.8% | — |
| Return on assets | -325.2% | -9.4% | -28.0% | -15.5% | -62.9% |
| Return on equity | 486.1% | -16.6% | -215.2% | -60.2% | -434.0% |
| Debt / equity | -0.04× | — | 1.34× | 0.08× | 1.46× |
| Current ratio | 0.48 | 2.12 | 0.96 | 1.18 | 0.88 |
| Revenue growth | 42.5% | -16.9% | -32.8% | 15.5% | -80.5% |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001789299 · as of 2025-03-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.